Prognostic factors affecting survival in non‐small cell lung carcinoma patients with malignant pleural effusions
- 15 April 2015
- journal article
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 10 (6), 791-799
- https://doi.org/10.1111/crj.12292
Abstract
Lung cancer is the most common cause of malignant pleural effusions (MPEs). For patients with lung cancer and MPE, median survival is only 3-4 months. The aim of this study was to evaluate lung cancer patients with MPE by clinical and laboratory findings on admission, and determine 2-year survival rate and prognostic factors.Between 2008 and 2011, we examined 199 cases of non-small cell lung carcinoma with MPE. Demographic factors of patients, tumor characteristics, treatment delivered and laboratory parameters affecting prognosis were evaluated. Survival rates were estimated by Kaplan-Meier method. Significance of each prognostic factors selected by univariate analysis were confirmed using Cox regression model.The study included 139 (69.8%) male and 60 (30.2%) female patients with a median age of 64 (30-85) years. Median overall survival was 4.4 months. Adenocarcinoma was the leading cause of MPE with 80.4%. A univariate analysis showed that factors affecting mortality included gender (P < 0.001), MPE with distant metastasis (P = 0.025), lower serum albumin (P < 0.0001), lower pleural protein (P < 0.0001), increased serum lactate dehydrogenase (P = 0.003), increased serum C-reactive protein (CRP) (P < 0.0001), increased white blood cells (P < 0.0001), histopathological type (P = 0.004) and treatment decision (P < 0.0001). A multivariate analysis revealed that patients who had high level of serum CRP (P = 0.017), lower serum albumin (P = 0.009) and lower pleural protein (P = 0.003), MPE with distant metastasis (P = 0.003) and those who were chemotherapy naive (P < 0.0001) had shorter survival.High level of serum CRP, lower serum albumin and lower pleural protein, MPE with distant metastasis were most important prognostic factors for non-small cell lung carcinoma in patients with MPEs.Keywords
This publication has 17 references indexed in Scilit:
- Lung cancer in Victoria: are we making progress?The Medical Journal of Australia, 2013
- Age is a prognostic factor affecting survival in lung cancer patientsOncology Letters, 2013
- Sex as an Independent Prognostic Factor in a Population-Based, Non-Small Cell Lung Cancer CohortCanadian Respiratory Journal, 2013
- Survival of lung adenocarcinoma patients with malignant pleural effusionEuropean Respiratory Journal, 2012
- Sex-associated differences in non-small cell lung cancer in the new era: Is gender an independent prognostic factor?Lung Cancer, 2009
- Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results DatabaseJournal of Clinical Oncology, 2007
- Prognostic factors for survival of stage I nonsmall cell lung cancer patientsCancer, 2007
- Pleural Fluid pH as a Predictor of Survival for Patients With Malignant Pleural EffusionsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2000
- Predicting Survival in Patients With Recurrent Symptomatic Malignant Pleural EffusionsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2000
- Lung Cancer and Pleural EffusionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1985